NR546 FINAL STUDY GUIDE FOR NURSING

NR546 FINAL STUDY GUIDE FOR NURSING .Acamprosate in pregnancy - ANSWER-Not recommended unless necessary for alcohol dependence. .Acetylcholine - ANSWER-Neurotransmitter important for memory and learning. .Acetylcholine (ACh) - ANSWER-Neurotransmitter crucial for memory and learning. .Activities of Daily Living (ADLs) - ANSWER-Basic self-care tasks like grooming and cooking. .Adjunctive Treatment - ANSWER-L-Methylfolate may help alongside antidepressants. .Aggression - ANSWER-Hostile or violent behavior towards others. .Agitation - ANSWER-State of nervousness or restlessness. .AGS Beers Criteria - ANSWER-Guidelines to avoid harmful medications in elderly. .Alcohol withdrawal symptoms - ANSWER-Mild symptoms include anxiety, tremors, and nausea. .Alzheimer's disease (AD) - ANSWER-Involves genetic and environmental factors. .Amyloid plaques - ANSWER-Toxic formations impair neuron function in AD. .Antidepressant Treatment Duration - ANSWER-Start for 4-8 weeks at lowest dose. .Antidepressants and Older Adults - ANSWER-May respond less robustly after age 65. .Antidepressants and Suicide Risk - ANSWER-Increase risk of death by suicide in youth. .Antipsychotic risks - ANSWER-Increased risk of falls, stroke, and cognitive decline. .Anxiety - ANSWER-Mental state of excessive worry or fear. .Atomoxetine - ANSWER-Non-abusive ADHD treatment, does not increase DA. .Behavioral Issues - ANSWER-Problems related to actions and conduct. .Benzodiazepines (BZOs) - ANSWER-Used cautiously for insomnia due to misuse risk. .Benzodiazepines for withdrawal - ANSWER-First-line treatment for alcohol withdrawal symptoms. .Biomarkers - ANSWER-Biological indicators of disease presence. .Bipolar Disorder Treatment - ANSWER-Combine antidepressants with mood stabilizers. .Breastfeeding contraindications - ANSWER-Avoid carbamazepine, lithium, and lamotrigine. .Buprenorphine in pregnancy - ANSWER-Increased risk of neonatal withdrawal syndrome. .Bupropion - ANSWER-Lowest risk of sexual side effects among antidepressants. .Carbamazepine risk - ANSWER-May cause syndrome of inappropriate antidiuretic hormone secretion (SIADH). .Caution with antipsychotics - ANSWER-Increased risk of falls in elderly patients. .Cholinergic neurons - ANSWER-Decreased in AD, linked to memory dysfunction. .Cholinesterase Inhibitors (ChEIs) - ANSWER-Medications that increase acetylcholine availability. .Citalopram Dosage in Older Adults - ANSWER-Should be given at half dose. .CIWA-Ar - ANSWER-Standardized tool for assessing alcohol withdrawal severity. .Cognitive Deficits - ANSWER-Impairments in mental processes like thinking. .Common Side Effects - ANSWER-Typical adverse reactions to medications. .Contraindications - ANSWER-Conditions that prevent medication use. .CYP450 Metabolism - ANSWER-Liver enzyme system affecting drug clearance. .Discontinuation Syndrome - ANSWER-More likely with paroxetine after stopping. .Disulfiram reaction - ANSWER-Can occur up to 14 days after alcohol consumption. .Donepezil - ANSWER-First-line treatment for moderate to severe AD. .Dopamine agonists for RLS - ANSWER-Include pramipexole and ropinirole as treatments.